In response to the COVID-19 pandemic, faculty in Cornell’s Public Health Program developed an innovative online training program to help boost skills in the public health workforce. A recent study recently reports that 94% of participants gained skills and knowledge they could apply directly to their work, and 86% developed a better understanding of public health.
Research findings suggest that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken estrogen.
Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain. This triggers a reaction that damages blood vessels and causes neurodegeneration.
Researchers have demonstrated the use of artificial-intelligence-selected natural images and AI-generated synthetic images as neuroscientific tools for probing the visual processing areas of the brain.
Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house.
A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow, confirming hypotheses about the anatomy of this tissue and providing a powerful new means to study diseases that affect bone marrow.
Weill Cornell Medicine has received a three-year, nearly $6 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to lead one of three national contraceptive research centers.
The Centers for Medicare and Medicaid Services has created a system in which Wall Street actors and insurance conglomerates have extracted large profits at the expense of Medicare, its patients and taxpayers – according to a new report co-authored by a Cornell professor.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.